Design
Review
Authors
Loading...
Does not alter clinical antiviral strategies; leaves open RNase L-independent OAS pathways for targeted investigation.
Key points are not available for this paper at this time.
Kristiansen et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: